NCT02444143View on ClinicalTrials.gov

A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

June 9, 2017

Conditions
Kidney Transplantation
Interventions
DRUG

tacrolimus extended release

Trial Locations (1)

60612

University of Illinois Hospital & Health Sciences System, Chicago

All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

University of Illinois at Chicago

OTHER

NCT02444143 - A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter